UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Kinase Fusion Gene:LYZ_IRAK1 |
Kinase Fusion Protein Summary |
Kinase Fusion gene summary |
Kinase Fusion partner gene information | Kinase Fusion gene name: LYZ_IRAK1 | KinaseFusionDB ID: KFG3254 | FusionGDB2.0 ID: KFG3254 | Hgene | Tgene | Gene symbol | LYZ | IRAK1 | Gene ID | 4069 | 3654 | |
Gene name | lysozyme | interleukin 1 receptor associated kinase 1 | ||||||||||
Synonyms | LYZF1|LZM | IRAK|pelle | ||||||||||
Cytomap | 12q15 | Xq28 | ||||||||||
Type of gene | protein-coding | protein-coding | ||||||||||
Description | lysozyme C1,4-beta-N-acetylmuramidase Cc-type lysozymelysozyme F1 | interleukin-1 receptor-associated kinase 1Pelle homolog | ||||||||||
Modification date | 20240407 | 20240305 | ||||||||||
UniProtAcc | Q7Z4W2 | Q5VVH5 | ||||||||||
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000261267, ENST00000548839, ENST00000549690, | ENST00000369974, ENST00000369980, ENST00000393682, ENST00000477274, ENST00000393687, ENST00000429936, | |||||||||
Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: LYZ [Title/Abstract] AND IRAK1 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | LYZ(69742294)-IRAK1(153276193), # samples:1 |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | LYZ | GO:0031640 | killing of cells of another organism | 9727055 |
Hgene | LYZ | GO:0042742 | defense response to bacterium | 21093056 |
Hgene | LYZ | GO:0050830 | defense response to Gram-positive bacterium | 21093056 |
Tgene | IRAK1 | GO:0046777 | protein autophosphorylation | 12054681 |
Tgene | IRAK1 | GO:0046777 | protein autophosphorylation | 10383454 |
Tgene | IRAK1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 10383454 |
Tgene | IRAK1 | GO:0070498 | interleukin-1-mediated signaling pathway | - |
Kinase Fusion gene breakpoints across LYZ (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Kinase Fusion gene breakpoints across IRAK1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
Kinase Fusion gene information. |
Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
ChimerDB4 | TCGA-AB-2844-03A | LYZ | chr12 | 69742294 | IRAK1 | chrX | 153276193 |
Top |
Kinase Fusion ORF Analysis |
Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:69742294/:153276193) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
LYZ | IRAK1 |
FUNCTION: Component of the IRAK1-dependent TNFRSF1A signaling pathway that leads to NF-kappa-B activation and is required for cell survival. Acts by enhancing RELA transcriptional activity (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
- Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of LYZ_IRAK1 |
Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
IRAK1 | P51617 | human | PELI1 | Q96FA3 | T80 | DQHsIsYtLsRAQtV | Pellino |
IRAK1 | P51617 | human | IRAK1 | P51617 | T387 | RtQTVRGtLAYLPEE | Pkinase |
IRAK1 | P51617 | human | PELI1 | Q96FA3 | S78 | NKDQHsIsYtLsRAQ | Pellino |
IRAK1 | P51617 | human | PELI1 | Q96FA3 | T86 | YtLsRAQtVVVEYTH | Pellino |
IRAK1 | P51617 | human | PELI1 | Q96FA3 | T288 | QCPVGFNtLAFPsMk | Pellino |
IRAK1 | P51617 | human | PELI1 | Q96FA3 | T127 | GSQSNsDtQSVQSTI | Pellino |
IRAK1 | P51617 | human | PELI2 | Q9HAT8 | T290 | QCPVGLNtLAFPsIN | Pellino |
IRAK1 | P51617 | human | IRAK1 | P51617 | T209 | LCEISRGtHNFSEEL | |
IRAK1 | P51617 | human | PELI1 | Q96FA3 | S293 | FNtLAFPsMkRkDVV | Pellino |
IRAK1 | P51617 | human | PELI1 | Q96FA3 | S125 | VPGSQSNsDtQSVQS | Pellino |
IRAK1 | P51617 | human | STAT3 | P40763 | S727 | NtIDLPMsPrTLDSL | |
IRAK1 | P51617 | human | PELI1 | Q96FA3 | S76 | IsNKDQHsIsYtLsR | Pellino |
IRAK1 | P51617 | human | PELI1 | Q96FA3 | S82 | HsIsYtLsRAQtVVV | Pellino |
IRAK1 | P51617 | human | PELI1 | Q96FA3 | S70 | PQAAKAIsNKDQHsI | Pellino |
Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
Enriched GO biological processes of the phosphorylation target genes of the kinase |
Kinase | GOID | GO term | P.adjust |
IRAK1 | ID | Description | 0.00e+00 |
IRAK1 | GO:0008063 | Toll signaling pathway | 2.09e-07 |
IRAK1 | GO:0043123 | positive regulation of canonical NF-kappaB signal transduction | 7.75e-04 |
IRAK1 | GO:0043122 | regulation of canonical NF-kappaB signal transduction | 1.28e-03 |
IRAK1 | GO:0007249 | canonical NF-kappaB signal transduction | 1.39e-03 |
IRAK1 | GO:0030522 | intracellular receptor signaling pathway | 1.81e-03 |
IRAK1 | GO:0140894 | endolysosomal toll-like receptor signaling pathway | 1.96e-03 |
IRAK1 | GO:0034142 | toll-like receptor 4 signaling pathway | 2.52e-03 |
IRAK1 | GO:0140895 | cell surface toll-like receptor signaling pathway | 2.84e-03 |
IRAK1 | GO:0001819 | positive regulation of cytokine production | 2.84e-03 |
IRAK1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway | 2.87e-03 |
IRAK1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 4.41e-03 |
IRAK1 | GO:0002753 | cytosolic pattern recognition receptor signaling pathway | 1.01e-02 |
IRAK1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.01e-02 |
IRAK1 | GO:0000209 | protein polyubiquitination | 2.13e-02 |
IRAK1 | GO:0002221 | pattern recognition receptor signaling pathway | 2.17e-02 |
IRAK1 | GO:0051091 | positive regulation of DNA-binding transcription factor activity | 2.17e-02 |
IRAK1 | GO:0002758 | innate immune response-activating signaling pathway | 2.23e-02 |
IRAK1 | GO:0002218 | activation of innate immune response | 2.27e-02 |
IRAK1 | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 2.27e-02 |
IRAK1 | GO:0045089 | positive regulation of innate immune response | 2.27e-02 |
IRAK1 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 2.27e-02 |
IRAK1 | GO:0032496 | response to lipopolysaccharide | 2.27e-02 |
IRAK1 | GO:0033210 | leptin-mediated signaling pathway | 2.27e-02 |
IRAK1 | GO:0060397 | growth hormone receptor signaling pathway via JAK-STAT | 2.27e-02 |
IRAK1 | GO:1903799 | negative regulation of miRNA processing | 2.27e-02 |
IRAK1 | GO:1905050 | positive regulation of metallopeptidase activity | 2.27e-02 |
IRAK1 | GO:0002237 | response to molecule of bacterial origin | 2.27e-02 |
IRAK1 | GO:0002833 | positive regulation of response to biotic stimulus | 2.27e-02 |
IRAK1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 2.27e-02 |
IRAK1 | GO:0035723 | interleukin-15-mediated signaling pathway | 2.27e-02 |
IRAK1 | GO:0070669 | response to interleukin-2 | 2.27e-02 |
IRAK1 | GO:0071350 | cellular response to interleukin-15 | 2.27e-02 |
IRAK1 | GO:2001223 | negative regulation of neuron migration | 2.27e-02 |
IRAK1 | GO:1903037 | regulation of leukocyte cell-cell adhesion | 2.27e-02 |
IRAK1 | GO:0060965 | negative regulation of miRNA-mediated gene silencing | 2.27e-02 |
IRAK1 | GO:0070672 | response to interleukin-15 | 2.27e-02 |
IRAK1 | GO:0106014 | regulation of inflammatory response to wounding | 2.27e-02 |
IRAK1 | GO:0051090 | regulation of DNA-binding transcription factor activity | 2.27e-02 |
IRAK1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway | 2.27e-02 |
IRAK1 | GO:0060149 | negative regulation of post-transcriptional gene silencing | 2.27e-02 |
IRAK1 | GO:0060967 | negative regulation of gene silencing by regulatory ncRNA | 2.27e-02 |
IRAK1 | GO:1900369 | negative regulation of post-transcriptional gene silencing by regulatory ncRNA | 2.27e-02 |
IRAK1 | GO:0007159 | leukocyte cell-cell adhesion | 2.27e-02 |
IRAK1 | GO:0045088 | regulation of innate immune response | 2.27e-02 |
IRAK1 | GO:0060019 | radial glial cell differentiation | 2.27e-02 |
IRAK1 | GO:0060221 | retinal rod cell differentiation | 2.27e-02 |
IRAK1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity | 2.27e-02 |
IRAK1 | GO:0072540 | T-helper 17 cell lineage commitment | 2.27e-02 |
IRAK1 | GO:1903798 | regulation of miRNA processing | 2.27e-02 |
Top |
Related Drugs to LYZ_IRAK1 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Distribution of the number of studies mentioning LYZ-IRAK1 and kinase inhibitors the PubMed Abstract (04-01-2024) |
Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to LYZ_IRAK1 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
MeSH ID | MeSH term |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
Clinical Trials from clinicaltrials.gov (06-17-2024) |
Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |